Published in Clin Pharmacol Ther on December 01, 1991
Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrob Agents Chemother (1994) 0.99
Disposition of acetaminophen and indocyanine green in cystic fibrosis-knockout mice. AAPS PharmSci (2000) 0.79
Drug clearance in patients with cystic fibrosis. Clin Pharmacol Ther (1992) 0.79
The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism. J Int Med Res (2017) 0.75
The effect of tocainide on theophylline metabolism. Br J Clin Pharmacol (1993) 0.75
Assessment of arylamine N-acetyltransferase (NAT1) activity in mononuclear leukocytes of cystic fibrosis patients. Br J Clin Pharmacol (1995) 0.75
Plasma concentrations and effects of salbutamol administered orally to patients with cystic fibrosis. Br J Clin Pharmacol (1995) 0.75
A review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdose. Open Access Emerg Med (2011) 0.75
Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic Fibrosis. Antimicrob Agents Chemother (2016) 0.75
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med (1994) 7.98
Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67
A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med (1999) 6.23
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis (2000) 4.93
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25
Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature (2000) 4.12
2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor. Bioorg Med Chem Lett (2000) 4.03
Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol (1993) 3.82
Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31
Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg (1992) 2.71
Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol (1997) 2.65
Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45
Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1981) 2.41
Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother (1986) 2.38
L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry (2000) 2.36
Is the acetylcholine receptor a rabies virus receptor? Science (1982) 2.30
Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother (1988) 2.28
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11
Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects. J Pediatr (1994) 2.10
Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1980) 2.07
Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child (1977) 2.04
Isolation and assay of rabies serogroup viruses in CER cells. Intervirology (1977) 2.03
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Characterization of Haemophilus influenzae type b fimbriae. Infect Immun (1984) 2.00
Antibiotics and invasive Haemophilus influenzae. N Engl J Med (1976) 2.00
Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol (1984) 1.95
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Sepsis and congenital asplenia. J Pediatr (1977) 1.93
T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.92
In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother (1981) 1.87
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85
Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis (1991) 1.84
Clinical staging in Reye syndrome. Am J Dis Child (1974) 1.84
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84
Isolation of field rabies virus strains in CER and murine neuroblastoma cell cultures. Intervirology (1978) 1.81
Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis (1999) 1.79
Lipid peroxidation by human blood phagocytes. J Clin Invest (1974) 1.79
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther (2008) 1.74
Riboflavin and mouse hepatic cell structure and function. II. Division of mitochondria during recovery from simple deficiency. J Cell Biol (1969) 1.74
A virulent nonencapsulated Haemophilus influenzae. J Infect Dis (1996) 1.73
A first-generation whole genome-radiation hybrid map spanning the mouse genome. Genome Res (1997) 1.73
Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax (2004) 1.71
Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest (1996) 1.70
Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70
The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study. BMC Med (2007) 1.69
Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing. Antimicrob Agents Chemother (1987) 1.67
Comparative virulence of Haemophilus influenzae with a type b or type d capsule. Infect Immun (1981) 1.66
Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65
Increasing incidence of ampicillin resistance in Hemophilus influenzae. J Pediatr (1978) 1.63
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis (1993) 1.63
Morphine pharmacokinetics in early infancy. Anesthesiology (1987) 1.61
Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharmacol Ther (2007) 1.61
Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 1.60
Urogenital, maternal and neonatal isolates of Haemophilus influenzae: identification of unusually virulent serologically non-typable clone families and evidence for a new Haemophilus species. J Gen Microbiol (1990) 1.59
Pigment gallstones form as a composite of bacterial microcolonies and pigment solids. Ann Surg (1987) 1.55
Clinical pharmacokinetics of zidovudine. An overview of current data. Clin Pharmacokinet (1989) 1.52
Host cell receptors for two strains of Sindbis virus. Arch Virol (1980) 1.51
In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1989) 1.49
Characterization of mouse parvovirus infection by in situ hybridization. J Virol (1995) 1.49
Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther (2009) 1.48
Psychiatric disorders in the first-degree relatives of probands with bulimia nervosa. Am J Psychiatry (1989) 1.46
Diagnosis of Wilson's disease: an experience over three decades. Gut (2000) 1.46
A call for health policy education in the medical school curriculum. JAMA (1995) 1.46
Suppression of airway inflammation by a natural acute infection of the intestinal epithelium. Mucosal Immunol (2008) 1.44
Barbiturate protection in cerebral hypoxia. Anesthesiology (1977) 1.44
Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther (2000) 1.44
Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab Invest (1991) 1.41
Effect of misoprostol on fat malabsorption in cystic fibrosis. Arch Dis Child (1988) 1.41
Acetylcholine receptor density and acetylcholinesterase activity in skeletal muscle of rats following thermal injury. Anesthesiology (1989) 1.41
Group A streptococcal infections of the skin and pharynx (second of two parts). N Engl J Med (1977) 1.39
Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery disease. J Invasive Cardiol (2000) 1.39
Laboratory animal medicine in a time of crisis. Comp Med (2001) 1.39
Pharmacokinetics of gentamicin in children and adults. J Infect Dis (1975) 1.39
Evaluation of a rapid beta-lactamase test for detecting ampicillin-resistant strains of Hemophilus influenzae type b. Pediatrics (1976) 1.39
Effect of chloramphenicol administration in drinking water on predictable steady-state serum concentrations of the drug in mice. Comp Med (2000) 1.39
College of American Pathologists and American Society for Reproductive Medicine accreditation of assisted reproductive technology (ART) laboratories is associated with a decrease in take home baby rates of reporting ART laboratories. Fertil Steril (2000) 1.39
Cerebral blood flow and metabolism: effects of anesthetic drugs and techniques. Anesthesiology (1972) 1.39
Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol (1993) 1.38
The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci (1993) 1.37
Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax (2001) 1.37
Age at primary infection with Salmonella enterica serovar Typhimurium in the chicken influences persistence of infection and subsequent immunity to re-challenge. Vet Immunol Immunopathol (2004) 1.35
Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions. Transplantation (1996) 1.34
Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. J Pediatr (1981) 1.33
Neonatal central nervous system infection due to Mycoplasma hominis. J Pediatr (1977) 1.32
Plasmid-mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis: molecular characterization of one strain and review of the literature. J Infect Dis (1984) 1.32
Sympatric speciation by allochrony in a seabird. Proc Natl Acad Sci U S A (2007) 1.32
Pharmacokinetics of three oral formulations of ciprofloxacin. Antimicrob Agents Chemother (1985) 1.31
Prognosis of babies with neonatal hepatitis. Arch Dis Child (1977) 1.30
The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child (1989) 1.29
A study of the factors affecting the metabolic clearance of quinine in malaria. Eur J Clin Pharmacol (1997) 1.28
Evolution of the major pilus gene cluster of Haemophilus influenzae. J Bacteriol (1998) 1.28
Salmonella enterica serovar Pullorum persists in splenic macrophages and in the reproductive tract during persistent, disease-free carriage in chickens. Infect Immun (2001) 1.27
Bone and joint infections caused by Kingella kingae: six cases and review of the literature. Rev Infect Dis (1988) 1.27
Chemistry and biology of natural and designed enediynes. Proc Natl Acad Sci U S A (1993) 1.27
Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models. Clin Pharmacol Ther (1986) 1.26
Rodent parvovirus infections. Lab Anim Sci (1996) 1.25